Cresco Labs Inc. Income Tax Effects Allocated Directly to Equity, Equity Transactions
Cresco Labs Inc. (CRLBF) reported Income Tax Effects Allocated Directly to Equity, Equity Transactions of $2.00 million for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-06.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxEffectsAllocatedDirectlyToEquityEquityTransactions · last filed 2026-03-06
| Period end | Income Tax Effects Allocated Directly to Equity, Equity Transactions 12 month |
|---|---|
| 2025-12-31 | $2.00M 40-F · filed 2026-03-06 |